Stay updated on Nivolumab and 177Lu-DOTA0-Tyr3-Octreotate Clinical Trial

Sign up to get notified when there's something new on the Nivolumab and 177Lu-DOTA0-Tyr3-Octreotate Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab and 177Lu-DOTA0-Tyr3-Octreotate Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    A banner announces updates to NIH websites and says that, during the transition, NIH content may use “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI).
    Difference
    1%
    Check dated 2026-10-25T02:05:45.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The footer now displays site revision v3.7.2 instead of v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-18T01:53:16.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The footer’s site revision number changes from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-11T02:23:02.000Z thumbnail image
  4. Check
    36 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, indicating the content is blocked or unavailable rather than showing the study details. This reflects an access restriction rather than a substantive change to the study data.
    Difference
    21%
    Check dated 2026-09-20T01:04:57.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.5 to v3.6.6, indicating a small update to the page's metadata. No study details or data were changed.
    Difference
    0.1%
    Check dated 2026-08-29T21:50:48.000Z thumbnail image
  6. Check
    78 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.4 to v3.6.5 in the footer. This indicates a small update to the page's version metadata and does not affect the study content or user-facing information.
    Difference
    0.0%
    Check dated 2026-08-08T23:40:35.000Z thumbnail image

Stay in the know with updates to Nivolumab and 177Lu-DOTA0-Tyr3-Octreotate Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab and 177Lu-DOTA0-Tyr3-Octreotate Clinical Trial page.